Related LncRNAs |
ID |
lncRNA Name |
Disease |
Method |
Sample |
Expression pattern |
Dysfunction type |
Description |
PMID |
Source |
EL0289 |
CDKN2B-AS1 |
diabetes mellitus |
N/A |
N/A |
N/A |
expression |
ANRIL is a recently discovered long non-coding RNA encoded in the chromosome 9p21 region. This locus is a hotspot for disease-associated polymorphisms, and it has been consistently associated with cardiovascular disease, and more recently with several cancers, diabetes, glaucoma, endometriosis among other conditions. |
23104877 |
LncRNADisease
|
EL0289 |
CDKN2B-AS1 |
diabetes mellitus |
N/A |
N/A |
N/A |
mutation |
Genetic variation in lncRNA genes causes disease and influences susceptibility |
23791884 |
LncRNADisease
|
EL0853 |
MALAT1 |
diabetes mellitus |
N/A |
N/A |
N/A |
expression |
In addition, MALAT1, a conserved lncRNA, was significantly upregulated in an RF/6A cell model of hyperglycemia, in the aqueous humor samples, and in fibrovascular membranes of diabetic patients. |
24436191 |
LncRNADisease
|
EL0853 |
MALAT1 |
diabetes mellitus |
N/A |
N/A |
N/A |
N/A |
MALAT1 expression is significantly upregulated in the retinas of STZ-induced diabetic rats and db/db mice. MALAT1 knockdown could obviously ameliorate DR in vivo, as shown by pericyte loss, capillary degeneration, microvascular leakage, and retinal inflammation. Moreover, MALAT1 knockdown could regulate retinal endothelial cell proliferation, migration, and tube formation in vitro. The crosstalk between MALAT1 and p38 MAPK signaling pathway is involved in the regulation of endothelial cell function. |
25356875 |
LncRNADisease
|
EL0862 |
Meg3 |
diabetes mellitus |
MEG3 knockdown |
STZ-induced diabetic mice |
N/A |
N/A |
knockdown also regulates retinal endothelial cell proliferation, migration, and tube formation in vitro |
26845358 |
|
EL1034 |
P2rx3 |
diabetes mellitus |
reverse transcription-polymerase chain reaction (RT-PCR), immunohistochemistry, and western blotting |
diabetic rat dorsal root ganglia (DRG) Diabetes mellitus (DM) patients' serum samples |
up-regulated |
interaction |
Uc.48+ siRNA treatment may alleviate the DNP by inhibiting the excitatory transmission mediated by the P2X3 receptor in DRG. |
26686228 |
|
|